When the same habits stop working, our expert team can help build a plan around your metabolism, appetite, and goals, so progress can start feeling possible again.
Explore weight loss treatments built around your goals
GLP-1s
A clinician-guided GLP-1 treatment plan designed to support appetite regulation, metabolic health, and long-term care beyond the scale.
Starting at$139/ mo
Microdosing Tirzepatide
New
A low-dose GLP-1 approach designed to work in sync with the body, which may help minimize side effects, quiet cravings, and support moderate weight loss.
Starting at$159/ mo
Microdosing Semaglutide
Microdosing Semaglutide is designed to work in sync with your body, which may minimize side effects and support moderate weight loss.
Starting at$99/ mo
Wegovy® Pill Access & Monitoring
New
Lose up to 20% of your body weight with Wegovy® Pill, the first FDA-approved oral GLP-1 for weight loss. A once-daily tablet that helps quiet hunger and food noise, without injections.
Starting at$199/ mo
Zepbound® Access & Monitoring
Lose 20% of your body weight with Zepbound®, a once-weekly FDA-approved injection that helps quiet hunger and food noise through dual GIP + GLP-1 support.
Starting at$364/ mo
Wegovy® Access & Monitoring
Lose meaningful weight with Wegovy®, a once-weekly FDA-approved GLP-1 injection shown to help adults lose 30+ lbs on average, quiet food noise, and lessen cravings.
Starting at$264/ mo
B12/MIC Injection
Support steady weight loss, restore energy, and promote healthy metabolism with a targeted blend of vitamin B12 and lipotropic nutrients tailored to enhance the body’s natural fat-burning systems.
Starting at$110/mo
Metformin
A once-daily pill that may help the body use sugar more efficiently, support appetite control, and build a stronger metabolic foundation for long-term health.
Starting at$25/mo
GLP-1s
A clinician-guided GLP-1 treatment plan designed to support appetite regulation, metabolic health, and long-term care beyond the scale.
Starting at$139/ mo
Microdosing Tirzepatide
New
A low-dose GLP-1 approach designed to work in sync with the body, which may help minimize side effects, quiet cravings, and support moderate weight loss.
Starting at$159/ mo
Microdosing Semaglutide
Microdosing Semaglutide is designed to work in sync with your body, which may minimize side effects and support moderate weight loss.
Starting at$99/ mo
Wegovy® Pill Access & Monitoring
New
Lose up to 20% of your body weight with Wegovy® Pill, the first FDA-approved oral GLP-1 for weight loss. A once-daily tablet that helps quiet hunger and food noise, without injections.
Starting at$199/ mo
Zepbound® Access & Monitoring
Lose 20% of your body weight with Zepbound®, a once-weekly FDA-approved injection that helps quiet hunger and food noise through dual GIP + GLP-1 support.
Starting at$364/ mo
Wegovy® Access & Monitoring
Lose meaningful weight with Wegovy®, a once-weekly FDA-approved GLP-1 injection shown to help adults lose 30+ lbs on average, quiet food noise, and lessen cravings.
Starting at$264/ mo
B12/MIC Injection
Support steady weight loss, restore energy, and promote healthy metabolism with a targeted blend of vitamin B12 and lipotropic nutrients tailored to enhance the body’s natural fat-burning systems.
Starting at$110/mo
Metformin
A once-daily pill that may help the body use sugar more efficiently, support appetite control, and build a stronger metabolic foundation for long-term health.
Starting at$25/mo
Feeling stuck shouldn’t be your new normal
Age, hormones, and stress can change how your body manages weight.1 The good news is there’s a specific mechanism behind this shift, and it’s the same one our plans are built to address.2
Our in-house team brings 199+ years of combined clinical experience to finding the right plan and pace for your body, then adjusts as you progress so you’re never left guessing what to do next.
Actual results may vary. Data was self-reported by 8,228 surveyed customers who checked in with their provider on their first and third check-in between 4/7/22-2/9/26. All respondents are AgelessRx customers who were approved for a prescription after completing an assessment with a medical provider.
Based on the manufacturer trial studying the highest dose of Wegovy® and Zepbound® in non-diabetics with obesity, when paired with diet and exercise changes.
Make progress feel possible again
Day 1
One of our in-house providers starts with what has changed, what you’ve tried, and where you want to go, then builds a plan around your health history and goals.
30 Days
Some may notice hunger feels quieter, portions feel easier, or fewer cravings interrupt the day, making consistency feel less like a constant negotiation.3
3 Months
As appetite and metabolic support build, healthy habits may begin translating into progress you can see and feel.4
6 Months
As your body responds, your care team can adjust your treatment, dose, or pace to support progress while helping manage side effects.
1 Year and Beyond
The focus shifts toward protecting what changed, supporting metabolic health, and building a plan that can carry your progress forward.
Day 1
One of our in-house providers starts with what has changed, what you’ve tried, and where you want to go, then builds a plan around your health history and goals.
30 Days
Some may notice hunger feels quieter, portions feel easier, or fewer cravings interrupt the day, making consistency feel less like a constant negotiation.3
3 Months
As appetite and metabolic support build, healthy habits may begin translating into progress you can see and feel.4
6 Months
As your body responds, your care team can adjust your treatment, dose, or pace to support progress while helping manage side effects.
1 Year and Beyond
The focus shifts toward protecting what changed, supporting metabolic health, and building a plan that can carry your progress forward.
Disclaimer
The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Prescription products require an online evaluation with a licensed medical professional who will determine if a prescription is appropriate. Products are compounded by a licensed pharmacy. The FDA has not reviewed or approved compounded products for any use for safety, efficacy, or quality. See above for important safety information. Benefits outlined on AgelessRx.com are based on 3rd party studies. Medication is offered as a subscription service which you can cancel at any time. Actual product packaging may appear differently than shown.
The right weight loss plan can make all the difference
When the scale stalls, you’re not left to start over on your own. Our fully in-house care team stays with you throughout your journey, adjusting your treatment, dose, and pace as your body responds.
We’re here to celebrate your progress, guide you through setbacks, and protect what you worked for, with plans starting at less than $1 a day.
We study the parts of weight loss most programs overlook
Weight loss is the visible part. It’s not the whole story. GLP-1 receptors exist throughout the body, and a growing body of research points to real metabolic and anti-inflammatory effects beyond the scale.5 6 7
Actual results may vary. Data was self-reported by 5,181 surveyed GLP-1 customers, 227 Microdosing Tirzepatide customers, and 4,803 Metformin customers who checked in with their provider between second and third check-in; dates 4/7/22-2/9/26. All respondents are AgelessRx GLP-1, Microdosing Tirzepatide, and Metformin customers who were approved for a prescription after completing an assessment with a medical provider.
Weight loss science you can actually use
We make cutting-edge science accessible, personal, and practically clear, so anyone can benefit from a longer, healthier life.
Start a personalized plan that helps quiet food noise, turn your effort into progress, and protect what you achieve, with an expert team beside you from day one through maintenance.
Your body’s clock is running 6 years younger than your chronological age.
This educational content medically reviewed by our experts
Dr. Jenell Decker, MD
Medical Director
Trusted expert in preventative care, integrative medicine, and longevity driven clinical practice.
Marshall University Joan C. Edwards School of Medicine
East Carolina University
Concord University
Frequently asked questions
01Should I start with Metformin, Microdosing GLP-1, or a full-dose GLP-1 for weight loss?
The right starting point depends on the amount of weight you want to lose, what you have already tried, how gradually you want to begin, as well as eligibility.
Metformin may be considered for metabolic support and more modest weight goals.⁹ Microdosing GLP-1 offers a lower-dose approach for gradual progress, food noise, or plateaus.⁸
Full-dose GLP-1s may be considered for more significant weight loss when medically appropriate, for those with a BMI > 27 looking to lose 20-50 lbs.²
A US-licensed medical provider will review your health history and goals to help find the right treatment, dose, and pace for your body. The FDA has not reviewed these statements or approved any compounded product for non-FDA-approved uses, such as weight management.
02What is the difference between Metformin, Microdosing GLP-1, and full-dose GLP-1 treatment for weight management?
Metformin is a once-daily pill that works through metabolic pathways involved in glucose regulation and may be considered as a more foundational option for metabolic health and modest weight goals.⁹
Microdosing GLP-1 uses lower amounts of Semaglutide or Tirzepatide compared to standard dosing and is designed for more gradual progress, plateaus, food noise, or moderate weight loss.⁸
Full-dose GLP-1 treatment uses standard or provider-recommended dosing and may be appropriate for more significant weight loss for those with a BMI > 27.²
The best option is not simply the strongest medication. It is the one that fits your goals, tolerability, and long-term plan.
03How can I maintain weight loss after reaching my goal or stopping a GLP-1?
Maintenance should be part of the plan before active weight loss ends. Your AgelessRx provider can help determine whether to continue treatment, adjust your dose, transition to another option, or build a longer-term strategy around your progress and health goals.
Our Stanford PhD-led Research Team is also studying Life After GLP-1s, including potential strategies to help people maintain the weight loss benefits they worked for after stopping medication.
04What happens if my GLP-1 side effects become difficult to manage?
Side effects do not always mean you have to abandon treatment. Your care team can review when symptoms started, how they relate to your dose, and whether your plan may need a different pace or adjustment.
Because we offer Microdosing GLP-1, full-dose GLP-1s, and non-GLP-1 options, your provider can consider more than one path forward rather than forcing the same approach to work for everyone.
Our idea of a page turner? Clinical trials.
We vet everything on PubMed so you don’t have to. Here’s what the science says.
1
This narrative review found that stress, sleep, and appetite-hormone shifts (leptin, ghrelin) persisting up to a year after weight loss can drive plateaus and regain.
2
This review found that GLP-1 receptor agonists act on brain appetite circuits, including hypothalamic orexin neurons, and on peripheral insulin, glucagon, and gut hormones to regulate hunger and energy balance.
3
This randomized, placebo-controlled crossover trial in 30 adults with obesity showed that once-weekly Semaglutide reduced hunger and food cravings and improved control of eating compared to placebo, alongside reduced energy intake and body weight.
4
This open-label randomized controlled trial in 751 adults with obesity (without type 2 diabetes) showed that Tirzepatide produced greater reductions in body weight and waist circumference than Semaglutide over 72 weeks.
5
This review of GLP-1 physiology across the gut-brain axis found that GLP-1 receptors are distributed throughout the body, including pancreatic beta cells, driving the incretin effect behind GLP-1’s glucose-lowering benefits.
6
This narrative review of Tirzepatide clinical trial data in adults with obesity and type 2 diabetes highlights favorable effects on glycemic control and lipid profile, including reduced HbA1c, LDL cholesterol, and triglycerides alongside increased HDL cholesterol.
7
This review found that GLP-1 receptor agonists have anti-inflammatory, healthspan-related benefits beyond diabetes and weight management, including potential effects on cardiovascular, kidney, and liver disease.
8
This retrospective cohort study in 363 patients with type 2 diabetes found that a lower 0.5 mg dose of Semaglutide produced weight loss and glycemic improvement comparable to the standard 1 mg dose.
9
This placebo-controlled study in women with obesity and type II diabetes showed that metformin reduced food intake and produced modest weight loss, with the effect being dose-dependent.